The philosophy surrounding recovery has also shifted
Disclosures: Johanna Schaub: Pliant Therapeutics: Employee, Pliant Therapeutics: Stock - publicly traded company, Richard Ahn: Nothing to Disclose, Fawzy Barry: Nothing to Disclose, Dorothea Kent: Nothing to Disclose, Prerna Kotak: Pliant Therapeutics: Stock - publicly traded company, Pliant Therapeutics: Employee, Scott Turner: Nothing to Disclose, Jennifer Lai: Nestle Nutrition Institute: Grant/Research Support, Novo Nordisk: Consultant, Genfit: Consultant, Boehringer Ingelheim: Advisor, Martin Decaris: Nothing to Disclose 2409 GALLBLADDER NEOPLASIA IS ASSOCIATED WITH A HIGHER RISK OF BILIARY NEOPLASIA IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS Mitchell Clayton 1 John Eaton 1 Ross Dierkhising 1 Andrea Gossard 1 Gregory Gores 1 Konstantinos Lazaridis 2 Nicholas LaRusso 1 , 1 Mayo Clinic Rochester, 2 Mayo Clinic Background: Chronic inflammation in those with primary sclerosing cholangitis (PSC) leads to a multifocal field effect, increasing the possibility of synchronous and metachronous neoplasia in the gallbladder (GBN) and biliary tree (BN)
Skip sugary mixers and heavy carbonation when possible many clinicians advise simpler drinks, roughly one standard drink per occasion, and one glass of water per alcoholic drink
,
